Xinhua Silk Road: Financial Street Forum annual conference to be held on Oct. 27-30 in Beijing
BEIJING, Oct. 20, 2025 /PRNewswire/ -- The annual conference of Financial Street Forum 2025 will be held on October 27-30 in Beijing. Over 400 delegates from more than 30 countries and regions will join the four-day conference, introduced by an...
Hindustan Zinc Achieves Highest Ever 2Q Revenue and EBITDA; PAT Surges 19% QoQ
UDAIPUR, India, Oct. 20, 2025 /PRNewswire/ -- India based Hindustan Zinc Limited, a Vedanta Group company and the world's largest integrated zinc producer, announced its financial results on 17th October 2025 for the second quarter and half year...
Osier Belle: Sydney's Most Luxurious Outdoor Furniture Finds a New Home
Australia's leading bespoke outdoor furniture brand opens an expansive new showroom in Neutral Bay, redefining how Australians experience outdoor living. SYDNEY, Oct. 20, 2025 /PRNewswire/ -- After 15 years of welcoming clients to its showroom,...
Antengene Presents Latest ATG-022 Clinical Data at ESMO 2025 Demonstrating Efficacy Across All CLDN18.2 Expression Levels and Exceptional Tolerability
SHANGHAI and HONG KONG, Oct. 20, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class...
Save Now, Travel through March: T'way Air Announces Fall Savings to Korea
Promo Code FLYOCT & Special Coupons for Travel through March 2026 TAIPEI, Oct. 20, 2025 /PRNewswire/ -- T'way Air, Korea's leading low-cost carrier, invites travelers to enjoy special savings through October 31 on Taiwan-Korea bookings for...
China's enduring commitment to peaceful development: a consistent path across past, present, and future
BEIJING, Oct. 20, 2025 /PRNewswire/ -- A report from People's Daily: Amid a turbulent and rapidly evolving global landscape, one principle remains consistent in China's international engagement: its unwavering commitment to peaceful development....
CARsgen Presents Preliminary Results on Satri-cel for Adjuvant Therapy of Pancreatic Cancer at ESMO Congress 2025
SHANGHAI, Oct. 20, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the research results of the Phase Ib registrational clinical trial...
Ascletis Completes Enrollment in U.S. Phase IIa Study for Its Once-Monthly Subcutaneous Depot Treatment Formulation of Small Molecule GLP-1R Agonist ASC30 for Obesity
- The 12-week U.S. Phase IIa study is evaluating the efficacy, safety and tolerability of the once-monthly subcutaneous (SQ) depot formulation (treatment formulation) of s mall m olecule GLP-1 receptor ( GLP-1R) a gonist ASC30 in 65 participants...